Assetmark, Inc Envista Holdings Corp Transaction History

Assetmark, Inc

$32.1 Billion
Q2 2024

A detailed history of Assetmark, Inc transactions in Envista Holdings Corp stock. As of the latest transaction made, Assetmark, Inc holds 36,489 shares of NVST stock, worth $699,859. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,489

Previous 19,534 86.8%

Holding current value

$699,859

Previous $417,000 45.32%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.0 - $21.1 $271,280 - $357,750	16,955 Added 86.8%	36,489 $606,000
Q1 2024 May 06, 2024	SELL	$20.64 - $25.45 $249,062 - $307,105	-12,067 Reduced 38.19%	19,534 $417,000
Q4 2023 Feb 09, 2024	BUY	$21.06 - $27.57 $104,836 - $137,243	4,978 Added 18.7%	31,601 $760,000
Q3 2023 Oct 27, 2023	SELL	$27.56 - $35.7 $20,752 - $26,882	-753 Reduced 2.75%	26,623 $742,000
Q2 2023 Aug 11, 2023	SELL	$31.53 - $39.74 $10,657 - $13,432	-338 Reduced 1.22%	27,376 $926,000
Q1 2023 May 05, 2023	BUY	$32.84 - $42.5 $24,794 - $32,087	755 Added 2.8%	27,714 $1.13 Million
Q4 2022 Feb 10, 2023	SELL	$32.54 - $37.99 $594,375 - $693,925	-18,266 Reduced 40.39%	26,959 $907,000
Q3 2022 Nov 01, 2022	BUY	$32.81 - $41.51 $295 - $373	9 Added 0.02%	45,225 $1.48 Million
Q2 2022 Aug 03, 2022	BUY	$35.59 - $48.1 $115,418 - $155,988	3,243 Added 7.73%	45,216 $1.74 Million
Q1 2022 May 13, 2022	SELL	$41.4 - $50.9 $79,322 - $97,524	-1,916 Reduced 4.37%	41,973 $2.05 Million
Q4 2021 Feb 14, 2022	BUY	$37.73 - $46.74 $139,185 - $172,423	3,689 Added 9.18%	43,889 $1.98 Million
Q3 2021 Nov 12, 2021	BUY	$39.75 - $44.09 $1.6 Million - $1.77 Million	40,200 New	40,200 $1.68 Million

Others Institutions Holding NVST

# of Institutions

315

Shares Held

200M

Call Options Held

128K

Put Options Held

52.4K

View Full List

About Envista Holdings Corp

Ticker NVST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 163,391,008
Market Cap $3.13B
Description
Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...

More about NVST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account